A new study finds that GLP-1 drugs’ heart health benefits may not be solely due to weight loss. The Good Brigade/Getty Images Building off this research, Deanfield is the lead author of a new study ...
People who stop taking popular weight-loss and diabetes medications may lose out on any heart health benefits the medications provided. GLP-1 receptor agonists — such as semaglutide (Ozempic and ...
A new study shows that popular weight‑loss drugs may help the heart after a person has a heart attack. These drugs are already used to help people lose weight or treat diabetes. Now researchers think ...
Hosted on MSN
Diabetes to weight loss to heart defence: Ozempic and Mounjaro protect against strokes and heart attacks, finds study
Two of the world’s most widely used diabetes and weight-loss medications, Ozempic and Mounjaro, may be doing far more than helping people control blood sugar and shed weight. A new study published in ...
New research suggests GLP-1s may help blood flow after a heart attack. GLP-1s have been linked to a lower risk of cardiovascular disease by helping people lose weight, but this new finding is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results